Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer
Abstract Cancer is highlighted as a major global health challenge in the XXI century. The cyclooxygenase-2 (COX-2) enzyme rises as a widespread tumor progression marker. Celecoxib (CXB) is a selective COX-2 inhibitor used in adjuvant cancer therapy, but high concentrations are required in humans. In...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer
2024-09-01
|
| Serier: | Discover Nano |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s11671-024-04070-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
